CUE - Cue Biopharma GAAP EPS of -$0.29 beats by $0.01 revenue of $1.38M beats by $0.47M August, 09 2023 04:50 PM Cue Biopharma Inc. 2023-08-09 16:50:27 ET Cue Biopharma press release ( NASDAQ: CUE ): Q2 GAAP EPS of -$0.29 beats by $0.01 . Revenue of $1.38M (+430.8% Y/Y) beats by $0.47M . For further details see: Cue Biopharma GAAP EPS of -$0.29 beats by $0.01, revenue of $1.38M beats by $0.47M